The recent challenges in global distribution have highlighted the value of securing critical medications like Ivermectin. Dependence on overseas vendors exposes countries to potential vulnerabilities, including transportation delays, expense fluctuations, and even trade risks. Transitioning towards domestic sourcing of Ivermectin offers a multitude